QA: BALCHEM CORP in us_medicinal_products/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000009326_2023_BALCHEM_CORP.pdf

Logs

info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0000009326, BALCHEM CORP

  xvar xval
0 LiabilitiesNoncurrent 40,620,000
1 LiabilitiesCurrent 202,826,000
2 remainder_Liabilities 442,782,000
3 AssetsCurrent 335,803,000
4 AssetsNoncurrent 32,212,000
5 PropertyPlantAndEquipmentNet 271,355,000
6 Goodwill 982,804,000
7 remainder_Assets 2,338,000
8 GeneralAndAdministrativeExpense 784,981,000
9 ResearchAndDevelopmentExpense 12,191,000
10 remainder_Expenses 28,382,000
11 remainder_Revenues 942,358,000
12 remainder_NetIncome -11,437,000
13 remainder_ComprehensiveNetIncome -2,161,000
  yvar yval
0 Liabilities 686,228,000
1 Assets 1,624,512,000
2 Expenses 825,554,000
3 Revenues 942,358,000
4 StockholdersEquity 938,284,000
5 NetIncome 105,367,000
6 ComprehensiveNetIncome 104,286,500
7 BaseVar 2,046,125,000
8 EconomicCapitalRatio 0.781

Edgar->Model Mapping

Feature Distribution

Change over Time